Enecadin Hydrochloride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameEnecadin Hydrochloride
Drug Alias NameZK-228326NS-7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockersVoltage-gated calcium channel blockersCalpain1/2 inhibitors
TargetsSodium channel alpha subunitVoltage-gated calcium channelCalpain1/2
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumAustriaGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Shinyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPaion Deutschland Gmbh
Active IndicationsN/A
Inactive IndicationsStroke

Other Information

ATC CodeN/A
Related LinksWikipedia